Genmab A/S Files 6-K Report
Ticker: GNMSF · Form: 6-K · Filed: Oct 1, 2024 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Oct 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 6-K
TL;DR
Genmab filed a 6-K, incorporating it into existing S-8 filings. Standard update.
AI Summary
Genmab A/S filed a Form 6-K on October 1, 2024, to report information for the month of October 2024. This filing is incorporated by reference into Genmab's existing S-8 registration statements (File Nos. 333-232693, 333-253519, 333-262970, and 333-277273). The company's principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Why It Matters
This filing serves as an update for investors and regulatory bodies, ensuring transparency regarding the company's ongoing reporting obligations.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates previous information and does not introduce new material risks.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 0001558370-24-013106 (filing_id) — Accession Number
- 20241001 (date) — Filing Date
- 333-232693 (registration_statement_id) — Form S-8 File Number
- 333-253519 (registration_statement_id) — Form S-8 File Number
- 333-262970 (registration_statement_id) — Form S-8 File Number
- 333-277273 (registration_statement_id) — Form S-8 File Number
FAQ
What is the purpose of this Form 6-K filing by Genmab A/S?
The Form 6-K is a report of a foreign private issuer filed for the month of October 2024, and it is incorporated by reference into Genmab's existing Form S-8 registration statements.
What are the file numbers for Genmab A/S's Form S-8 registration statements mentioned in the filing?
The mentioned Form S-8 registration statements have file numbers 333-232693, 333-253519, 333-262970, and 333-277273.
When was this Form 6-K filed?
This Form 6-K was filed on October 1, 2024.
Where are Genmab A/S's principal executive offices located?
Genmab A/S's principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Does this filing supersede previous reports?
This report on Form 6-K shall be deemed to be incorporated by reference into Genmab A/S's registration statements and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
Filing Stats: 210 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2024-10-01 10:33:41
Filing Documents
- tmb-20241001x6k.htm (6-K) — 19KB
- tmb-20241001xex3d1.htm (EX-3.1) — 274KB
- 0001558370-24-013106.txt ( ) — 294KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF OCTOBER 2024 COMMISSION FILE NUMBER 001-38976 Genmab A/S (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970 and 333-277273 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GENMAB A/S BY: /s/ Anthony Pagano Name: Anthony Pagano Title: Executive Vice President & Chief Financial Officer DATE: October 1, 2024 EXHIBIT INDEX Exhibit Description of Exhibit 3.1 Articles of Association